(Q45556409)

14 December 2017

title

Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity (English)

1 reference

14 December 2017

1 reference

Xin Zheng

1

1 reference

14 December 2017

Klaus M Weinberger

2

1 reference

14 December 2017

Ralph Gehrke

3

1 reference

14 December 2017

Masanori Isogawa

4

1 reference

14 December 2017

Gero Hilken

5

1 reference

14 December 2017

Thekla Kemper

6

1 reference

14 December 2017

Yang Xu

7

1 reference

14 December 2017

Dongliang Yang

8

1 reference

14 December 2017

Wolfgang Jilg

9

1 reference

14 December 2017

Michael Roggendorf

10

1 reference

14 December 2017

Mengji Lu

11

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

14 December 2017

1 reference

14 December 2017

volume

329

1 reference

14 December 2017

issue

2

1 reference

14 December 2017

page(s)

454-464

1 reference

Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

The clinical significance of surface antigen variants of hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Vaccine-induced escape mutant of hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Antigenic characterization of pre- and post-liver transplant hepatitis B surface antigen sequences from patients treated with hepatitis B immune globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Altered antigenicity of 'a' determinant variants of hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring "a" loop escape mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): composition, structure and immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Mutations in the 'a' determinant of hepatitis B surface antigen among Chinese infants receiving active postexposure hepatitis B immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

The effect of introduction of universal childhood hepatitis B immunization in South Africa on the prevalence of serologically negative hepatitis B virus infection and the selection of immune escape variants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

A novel hepatitis B virus variant in the sera of immunized children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Detection of Hepatitis B Surface Gene Mutation in Carrier Children with or without Immunoprophylaxis at Birth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

De Novo Infection in a Renal Transplant Recipient Caused by Novel Mutants of Hepatitis B Virus Despite the Presence of Protective Anti–Hepatitis B Surface Antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Secretion and antigenicity of hepatitis B virus small envelope proteins lacking cysteines in the major antigenic region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Location and chemical synthesis of a pre-S gene coded immunodominant epitope of hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

A new immune escape mutant of hepatitis B virus with an Asp to Ala substitution in aa144 of the envelope major protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Infectivity and pathogenicity in chimpanzees of a surface gene mutant of hepatitis B virus that emerged in a vaccinated infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Intra-familial evidence of horizontal transmission of hepatitis B virus surface antigen mutant G145R.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Targeting murine immune responses to selected T cell- or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Different immunogenicity of H-2 Kb-restricted epitopes in natural variants of the hepatitis B surface antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Effect of variation in the common "a" determinant on the antigenicity of hepatitis B surface antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Hepatitis B virus markers in anti-HBc only positive individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

A novel hepatitis B virus variant S 129 (Gln?Leu): Lack of correlation between antigenicity and immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

Naturally occurring variants of hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.08.033

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2004.08.033

1 reference

14 December 2017

1 reference